{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T04:17:18Z","timestamp":1787977038501,"version":"build-2784847793"},"reference-count":32,"publisher":"Pharmaceutical Society of Japan","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2026,8,28]]},"DOI":"10.1248\/bpb.b26-00037","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T22:11:09Z","timestamp":1787868669000},"page":"1320-1328","source":"Crossref","is-referenced-by-count":0,"title":["Bidirectional Regulation of c-Myc and TRB1 Establishes Oncogenic Reciprocal Regulation"],"prefix":"10.1248","volume":"49","author":[{"given":"Yuya","family":"Suzuki","sequence":"first","affiliation":[{"name":"Department of Cell Signaling, Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya 467\u20138603, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai","family":"Nagasaka","sequence":"first","affiliation":[{"name":"Department of Cell Signaling, Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya 467\u20138603, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiharu","family":"Miyajima","sequence":"additional","affiliation":[{"name":"Department of Cell Signaling, Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya 467\u20138603, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaori","family":"Tsuzuki","sequence":"additional","affiliation":[{"name":"Department of Cell Signaling, Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya 467\u20138603, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mau","family":"Suzuka","sequence":"additional","affiliation":[{"name":"Department of Cell Signaling, Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya 467\u20138603, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koh","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Cell Signaling, Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya 467\u20138603, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Morishita","sequence":"additional","affiliation":[{"name":"Department of Cell Signaling, Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya 467\u20138603, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohki","family":"Toriuchi","sequence":"additional","affiliation":[{"name":"Department of Pathobiology, Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya 467\u20138603, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromasa","family":"Aoki","sequence":"additional","affiliation":[{"name":"Department of Pathobiology, Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya 467\u20138603, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mineyoshi","family":"Aoyama","sequence":"additional","affiliation":[{"name":"Department of Pathobiology, Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya 467\u20138603, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetoshi","family":"Hayashi","sequence":"additional","affiliation":[{"name":"Department of Cell Signaling, Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya 467\u20138603, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasumichi","family":"Inoue","sequence":"additional","affiliation":[{"name":"Department of Cell Signaling, Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya 467\u20138603, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Dhanasekaran R, Deutzmann A, Mahauad-Fernandez WD, Hansen AS, Gouw AM, Felsher DW. The <i>MYC<\/i> oncogene\u2014the grand orchestrator of cancer growth and immune evasion. <i>Nat. Rev. Clin. Oncol.<\/i>, <b>19<\/b>, 23\u201336 (2022).","DOI":"10.1038\/s41571-021-00549-2"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Eilers M, Eisenman RN. Myc\u2019s broad reach. <i>Genes Dev.<\/i>, <b>22<\/b>, 2755\u20132766 (2008).","DOI":"10.1101\/gad.1712408"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Dang CV. <i>MYC<\/i> on the path to cancer. <i>Cell<\/i>, <b>149<\/b>, 22\u201335 (2012).","DOI":"10.1016\/j.cell.2012.03.003"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Llombart V, Mansour MR. Therapeutic targeting of \u201cundruggable\u201d MYC. <i>EBioMedicine<\/i>, <b>75<\/b>, 103756 (2022).","DOI":"10.1016\/j.ebiom.2021.103756"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Wang C, Zhang J, Yin J, Gan Y, Xu S, Gu Y, Huang W. Alternative approaches to target Myc for cancer treatment. <i>Signal Transduct. Target. Ther.<\/i>, <b>6<\/b>, 117 (2021).","DOI":"10.1038\/s41392-021-00500-y"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Eyers PA, Keeshan K, Kannan N. Tribbles in the 21st century: the evolving roles of tribbles pseudokinases in biology and disease. <i>Trends Cell Biol.<\/i>, <b>27<\/b>, 284\u2013298 (2017).","DOI":"10.1016\/j.tcb.2016.11.002"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) R\u00f6thlisberger B, Heizmann M, Bargetzi MJ, Huber AR. <i>TRIB1<\/i> overexpression in acute myeloid leukemia. <i>Cancer Genet. Cytogenet.<\/i>, <b>176<\/b>, 58\u201360 (2007).","DOI":"10.1016\/j.cancergencyto.2007.03.003"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Richmond L, Keeshan K. Pseudokinases: a tribble-edged sword. <i>FEBS J.<\/i>, <b>287<\/b>, 4170\u20134182 (2020).","DOI":"10.1111\/febs.15096"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Jadhav KS, Bauer RC. Trouble With Tribbles-1: Elucidating the Mechanism of a Genome-Wide Association Study Locus. <i>Arterioscler. Thromb. Vasc. Biol.<\/i>, <b>39<\/b>, 998\u20131005 (2019).","DOI":"10.1161\/ATVBAHA.118.311573"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Johnston J, Basatvat S, Ilyas Z, Francis S, Kiss-Toth E. Tribbles in inflammation. <i>Biochem. Soc. Trans.<\/i>, <b>43<\/b>, 1069\u20131074 (2015).","DOI":"10.1042\/BST20150095"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Nakamura T. The role of Trib1 in myeloid leukaemogenesis and differentiation. <i>Biochem. Soc. Trans.<\/i>, <b>43<\/b>, 1104\u20131107 (2015).","DOI":"10.1042\/BST20150110"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Yoshida A, Kato JY, Nakamae I, Yoneda-Kato N. COP1 targets C\/EBP\u03b1 for degradation and induces acute myeloid leukemia <i>via<\/i> Trib1. <i>Blood<\/i>, <b>122<\/b>, 1750\u20131760 (2013).","DOI":"10.1182\/blood-2012-12-476101"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Miyajima C, Inoue Y, Hayashi H. Pseudokinase tribbles 1 (TRB1) negatively regulates tumor-suppressor activity of p53 through p53 deacetylation. <i>Biol. Pharm. Bull.<\/i>, <b>38<\/b>, 618\u2013624 (2015).","DOI":"10.1248\/bpb.b15-00003"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Wang L, Liu X, Ren Y, Zhang J, Chen J, Zhou W, Guo W, Wang X, Chen H, Li M, Yuan X, Zhang X, Yang J, Wu C. Cisplatin-enriching cancer stem cells confer multidrug resistance in non-small cell lung cancer <i>via<\/i> enhancing TRIB1\/HDAC activity. <i>Cell Death Dis.<\/i>, <b>8<\/b>, e2746 (2017).","DOI":"10.1038\/cddis.2016.409"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Nagasaka M, Inoue Y, Yoshida M, Miyajima C, Morishita D, Tokugawa M, Nakamoto H, Sugano M, Ohoka N, Hayashi H. The deubiquitinating enzyme USP17 regulates c-Myc levels and controls cell proliferation and glycolysis. <i>FEBS Lett.<\/i>, <b>596<\/b>, 465\u2013478 (2022).","DOI":"10.1002\/1873-3468.14296"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Nagasaka M, Inoue Y, Nagao Y, Miyajima C, Morishita D, Aoki H, Aoyama M, Imamura T, Hayashi H. SET8 is a novel negative regulator of TGF-\u03b2 signaling in a methylation-independent manner. <i>Sci. Rep.<\/i>, <b>13<\/b>, 22877 (2023).","DOI":"10.1038\/s41598-023-49961-x"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Nagasaka M, Tsuzuki K, Ozeki Y, Tokugawa M, Ohoka N, Inoue Y, Hayashi H. Lysine-specific demethylase 1 (LSD1\/KDM1A) is a novel target gene of c-Myc. <i>Biol. Pharm. Bull.<\/i>, <b>42<\/b>, 481\u2013488 (2019).","DOI":"10.1248\/bpb.b18-00892"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Inoue Y, Iemura S, Natsume T, Miyazawa K, Imamura T. Suppression of p53 activity through the cooperative action of Ski and histone deacetylase SIRT1. <i>J. Biol. Chem.<\/i>, <b>286<\/b>, 6311\u20136320 (2011).","DOI":"10.1074\/jbc.M110.177683"},{"key":"19","unstructured":"19) Wang Z, Yang B, Zhang M, Guo W, Wu Z, Wang Y, Jia L, Li S, Xie W, Yang D. lncRNA epigenetic landscape analysis identifies <i>EPIC1<\/i> as an oncogenic lncRNA that interacts with MYC and promotes cell-cycle progression in cancer. <i>Cancer Cell<\/i>, <b>33<\/b>, 706\u2013720.e9 (2018)."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Nagasaka M, Hashimoto R, Inoue Y, Ishiuchi K, Matsuno M, Itoh Y, Tokugawa M, Ohoka N, Morishita D, Mizukami H, Makino T, Hayashi H. Anti-tumorigenic activity of chrysin from <i>Oroxylum indicum<\/i> via non-genotoxic p53 activation through the ATM-Chk2 pathway. <i>Molecules<\/i>, <b>23<\/b>, 1394 (2018).","DOI":"10.3390\/molecules23061394"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. <i>Nucleic Acids Res.<\/i>, <b>45<\/b> (W1), W98\u2013W102 (2017).","DOI":"10.1093\/nar\/gkx247"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Zou Z, Ohta T, Miura F, Oki S. ChIP-Atlas 2021 update: a data-mining suite for exploring epigenomic landscapes by fully integrating ChIP-seq, ATAC-seq and Bisulfite-seq data. <i>Nucleic Acids Res.<\/i>, <b>50<\/b> (W1), W175\u2013W182 (2022).","DOI":"10.1093\/nar\/gkac199"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Robinson D, Van Allen EM, Wu YM, <i>et al<\/i>. Integrative clinical genomics of advanced prostate cancer. <i>Cell<\/i>, <b>161<\/b>, 1215\u20131228 (2015).","DOI":"10.1016\/j.cell.2015.05.001"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Horiuchi D, Kusdra L, Huskey NE, Chandriani S, Lenburg ME, Gonzalez-Angulo AM, Creasman KJ, Bazarov AV, Smyth JW, Davis SE, Yaswen P, Mills GB, Esserman LJ, Goga A. MYC pathway activation in triple-negative breast cancer is synthetic lethal with CDK inhibition. <i>J. Exp. Med.<\/i>, <b>209<\/b>, 679\u2013696 (2012).","DOI":"10.1084\/jem.20111512"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Das SK, Kuzin V, Cameron DP, Sanford S, Jha RK, Nie Z, Rosello MT, Holewinski R, Andresson T, Wisniewski J, Natsume T, Price DH, Lewis BA, Kouzine F, Levens D, Baranello L. MYC assembles and stimulates topoisomerases 1 and 2 in a \u201ctopoisome\u201d. <i>Mol. Cell<\/i>, <b>82<\/b>, 140\u2013158.e12 (2022).","DOI":"10.1016\/j.molcel.2021.11.016"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Lee BK, Bhinge AA, Battenhouse A, McDaniell RM, Liu Z, Song L, Ni Y, Birney E, Lieb JD, Furey TS, Crawford GE, Iyer VR. Cell-type specific and combinatorial usage of diverse transcription factors revealed by genome-wide binding studies in multiple human cells. <i>Genome Res.<\/i>, <b>22<\/b>, 9\u201324 (2012).","DOI":"10.1101\/gr.127597.111"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Dang CV, O\u2019Donnell KA, Zeller KI, Nguyen T, Osthus RC, Li F. The c-Myc target gene network. <i>Semin. Cancer Biol.<\/i>, <b>16<\/b>, 253\u2013264 (2006).","DOI":"10.1016\/j.semcancer.2006.07.014"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Bretones G, Delgado MD, Le\u00f3n J. Myc and cell cycle control. <i>Biochim. Biophys. Acta. Gene Regul. Mech.<\/i>, <b>1849<\/b>, 506\u2013516 (2015).","DOI":"10.1016\/j.bbagrm.2014.03.013"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Dong Y, Tu R, Liu H, Qing G. Regulation of cancer cell metabolism: oncogenic MYC in the driver\u2019s seat. <i>Signal Transduct. Target. Ther.<\/i>, <b>5<\/b>, 124 (2020).","DOI":"10.1038\/s41392-020-00235-2"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Chahine JJ, Davis SS, Culfaci S, Kallakury BV, Tuma PL. Chromosome 8q24 amplification associated with human hepatocellular carcinoma predicts MYC\/ZEB1\/MIZ1 transcriptional regulation. <i>Sci. Rep.<\/i>, <b>14<\/b>, 24488 (2024).","DOI":"10.1038\/s41598-024-75219-1"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Ibragimova MK, Tsyganov MM, Pevzner AM, Litviakov NV. Transcriptome of breast tumors with different amplification status of the long arm of chromosome 8. <i>Anticancer Res.<\/i>, <b>41<\/b>, 187\u2013195 (2021).","DOI":"10.21873\/anticanres.14764"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Jin DH, Park SE, Lee J, Kim KM, Kim S, Kim DH, Park J. Copy number gains at 8q24 and 20q11-q13 in gastric cancer are more common in intestinal-type than diffuse-type. <i>PLOS ONE<\/i>, <b>10<\/b>, e0137657 (2015).","DOI":"10.1371\/journal.pone.0137657"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/49\/8\/49_b26-00037\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T03:28:11Z","timestamp":1787974091000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/49\/8\/49_b26-00037\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,28]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b26-00037","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,28]]},"article-number":"b26-00037"}}